Reverse T3: How to Interpret Your Result

What Reverse T3 Is and Why It Matters

Reverse T3 is a structural mirror image of active triiodothyronine (T3). The body produces it by removing iodine from the 5-position of T4 rather than the 5-prime position, a reaction catalyzed primarily by type 1 iodothyronine deiodinase (D1). The result is a molecule that fits the T3 receptor without activating it, effectively occupying the lock without turning the key.

Under normal physiology, roughly 20% of circulating T4 converts to rT3 as a routine clearance pathway. That percentage climbs sharply during physiological stress. The process is tightly regulated by selenoproteins, cortisol, and tissue-level enzyme activity rather than pituitary TSH, which is why a completely normal TSH does not rule out elevated rT3.

The Deiodinase Enzyme System

Three deiodinase enzymes govern thyroid hormone metabolism. D1 is expressed heavily in liver and kidney; it converts T4 to both active T3 and inactive rT3. D2 operates in the brain, pituitary, and skeletal muscle, favoring active T3 production. D3 inactivates both T3 and T4 by producing rT3 and T2 respectively.

During illness or starvation, D1 activity falls and D3 activity rises. That shift is the primary reason rT3 accumulates and free T3 drops simultaneously, a pattern researchers first described in fasting subjects in the 1970s and later quantified in ICU patients. A 1976 study in the New England Journal of Medicine by Vagenakis et al. Showed significant rT3 elevation during low-calorie diets, establishing the diet-conversion link.

The T3 Receptor Competition Mechanism

Active T3 binds nuclear thyroid hormone receptors (TRalpha and TRbeta) with high affinity. Reverse T3 also binds these receptors, though its activation efficiency is negligible. When rT3 levels are disproportionately high relative to free T3, it may reduce the net signal reaching mitochondria, slowing basal metabolic rate, cardiac output, and thermogenesis. Research published in Endocrinology has documented rT3's receptor-binding affinity relative to T3, confirming its antagonist-like behavior at physiological concentrations.

What the Normal Reverse T3 Range Looks Like

Most commercial laboratories report a reference interval of approximately 9.2 to 24.1 ng/dL, though the exact cutoffs vary by assay platform. Quest Diagnostics and LabCorp publish slightly different ranges based on their radioimmunoassay calibrations, so always compare your result against the reference interval printed on your own report.

Expressing rT3 in SI units, 9.2 ng/dL corresponds to roughly 141 pmol/L and 24.1 ng/dL to roughly 370 pmol/L. Your lab report should specify the unit used.

Why Population-Based Ranges Have Limits

Reference ranges are derived from the middle 95% of a tested population. That population likely included people with subclinical illness, poor sleep, and chronic stress, all conditions that raise rT3. A result of 23 ng/dL is technically "normal" by this definition, but for a person with fatigue and normal TSH it may still represent impaired conversion.

This is precisely why the American Association of Clinical Endocrinologists (AACE) does not list rT3 as a standard first-tier thyroid test. The AACE clinical practice guidelines for hypothyroidism emphasize TSH with reflex free T4 as the primary diagnostic pair, reserving additional tests for specific clinical situations.

The Free T3-to-rT3 Ratio

Many integrative and functional medicine clinicians use the ratio of free T3 (in pg/mL) divided by rT3 (in ng/dL) as a more nuanced marker. A ratio below 1.8 is considered by some practitioners to suggest functional hypothyroidism at the tissue level even when TSH sits within range. A 2005 paper in Thyroid demonstrated that critically ill patients with low free T3-to-rT3 ratios had measurably worse outcomes than those with ratios above 2.0, though the authors cautioned against generalizing ICU data to outpatient populations.

The ratio is not endorsed by the American Thyroid Association as a clinical standard, but it provides useful context when symptoms and standard labs do not align.

What a High Reverse T3 Result Means

A result above 24.1 ng/dL (or above your lab's upper reference limit) indicates that the body is shunting more T4 into the inactive pathway. This does not automatically mean disease. In the right context, it is an adaptive response, your body's attempt to conserve energy during stress or illness.

The clinical question is whether the elevation is proportionate and expected, or whether it is disproportionate and driving symptoms.

Causes of Elevated Reverse T3

Several well-documented causes exist:

• Critical illness and surgery. Serum rT3 rises within 24 hours of major surgery or ICU admission. A landmark paper in the Journal of Clinical Endocrinology and Metabolism (Wartofsky and Burman, 1982) catalogued the full "non-thyroidal illness syndrome" (NTIS) picture, including rT3 elevation as a central feature.
• Caloric restriction below approximately 800 kcal per day. The Vagenakis 1976 data remain the most-cited evidence for diet-induced rT3 elevation.
• Elevated cortisol. Chronic psychological stress, exogenous glucocorticoid therapy (such as prednisone at doses above 7.5 mg/day), or endogenous Cushing syndrome all suppress D1 activity. A study in Clinical Endocrinology showed that hydrocortisone infusion at stress doses significantly increased the T4-to-rT3 conversion rate within 48 hours.
• Selenium deficiency. Deiodinase enzymes are selenoproteins. Low selenium (serum below 70 mcg/L) impairs D1 function and may shift conversion toward rT3. The European Thyroid Journal has published evidence linking selenium status to deiodinase activity in populations with marginal intake.
• Amiodarone. This antiarrhythmic drug is iodine-rich and a potent inhibitor of D1 and D2, reliably raising rT3 by 2 to 3 times baseline within weeks of starting treatment.
• Beta-blockers and propylthiouracil (PTU). Both inhibit peripheral T4-to-T3 conversion and modestly raise rT3.

Symptoms Associated With High Reverse T3

Symptoms are not specific to rT3 elevation, but the cluster that most often prompts clinicians to check rT3 includes: persistent fatigue despite normal TSH, cold intolerance, hair thinning, brain fog, unexplained weight gain, and low basal body temperature.

None of these symptoms alone confirms a clinically significant rT3 problem. They must be interpreted alongside free T3, free T4, TSH, TPO antibodies, and clinical history.

Should You Treat a High Reverse T3?

The primary treatment is correcting the underlying cause, not the rT3 number itself. If a patient is recovering from major illness, rT3 typically normalizes within 4 to 6 weeks without intervention. If cortisol excess is the driver, addressing the stressor, adjusting glucocorticoid dosing, or treating Cushing syndrome takes priority. Selenium supplementation at 100 to 200 mcg of selenomethionine per day may help restore deiodinase activity in confirmed deficiency, though evidence from randomized trials in non-thyroidal illness remains limited.

Some clinicians prescribe liothyronine (synthetic T3, brand name Cytomel) to bypass the blocked conversion step. A randomized trial published in the New England Journal of Medicine by Bunevicius et al. (N=33) found that replacing 50 mcg of levothyroxine with 12.5 mcg of liothyronine improved mood and neuropsychological function in hypothyroid patients, suggesting combination therapy may benefit patients with conversion impairment. The Endocrine Society's 2012 guidelines on hypothyroidism acknowledge this trial but stop short of recommending routine combination therapy, citing variable patient responses and the need for larger studies.

HealthRX Clinical Decision Framework: When to Act on a High rT3

Use this four-step checklist before initiating treatment based on elevated rT3:

1. Confirm rT3 is above your lab's upper reference limit AND free T3 is below the lower third of its reference range.
2. Calculate the free T3-to-rT3 ratio. A ratio below 1.8 (with free T3 in pg/mL and rT3 in ng/dL) supports a clinically meaningful conversion deficit.
3. Rule out acute illness, recent surgery, or active starvation as transient causes.
4. Check serum cortisol, selenium, ferritin (below 50 ng/mL impairs conversion), and a full iron panel before attributing elevation to primary thyroid pathology.

Only after completing all four steps should a provider consider T3-containing therapy or further endocrinology referral.

What a Low Reverse T3 Result Means

A result below 9.2 ng/dL is less commonly discussed but is clinically meaningful in specific settings. Low rT3 generally indicates that the T4-to-rT3 conversion pathway is suppressed, which can happen for several reasons.

Causes of Low Reverse T3

• Hyperthyroidism. Graves disease and toxic nodular goiter accelerate overall thyroid hormone turnover. T4 is rapidly cleared and converted predominantly to active T3, leaving less substrate for rT3 production.
• Exogenous T3 therapy (liothyronine or desiccated thyroid extract). Taking supplemental T3 suppresses TSH, which in turn reduces T4 output. Less T4 substrate means less rT3 produced. A patient on adequate liothyronine dosing should be expected to have low or low-normal rT3.
• Very low T4 substrate. Severe hypothyroidism before treatment, or complete thyroidectomy on no replacement therapy, will reduce both T4 and its metabolites, including rT3.

Low rT3 in the context of normal or elevated free T3 and suppressed TSH is consistent with hyperthyroidism and warrants further evaluation with a thyroid uptake scan or TSH receptor antibody testing. Low rT3 in a patient already on T3-containing therapy is an expected pharmacologic finding.

How to Lower a High Reverse T3

Lowering rT3 without addressing its root cause is treating a lab value rather than a patient. Several evidence-informed strategies reduce rT3 by correcting the upstream drivers.

Address Cortisol Dysregulation

Chronic hypothalamic-pituitary-adrenal axis activation is the most commonly overlooked driver of elevated rT3 in outpatient practice. A 24-hour urinary cortisol or a morning serum cortisol (normal reference: roughly 6 to 23 mcg/dL at 8 a.m.) can screen for overt hypercortisolism. Sleep optimization, stress reduction, and evaluation for sleep apnea (which raises 24-hour cortisol by disrupting the normal nocturnal nadir) are first-line non-pharmacologic steps.

Optimize Nutritional Cofactors

Selenium, zinc, and iron are all required for normal deiodinase and thyroid peroxidase function. A ferritin level below 50 ng/mL, serum zinc below 70 mcg/dL, or serum selenium below 70 mcg/L may each independently impair T4-to-T3 conversion and push production toward rT3. Repleting these with food sources or supplementation is low-risk and may produce measurable improvement in the free T3-to-rT3 ratio within 8 to 12 weeks.

Avoid Prolonged Very-Low-Calorie Diets

Sustained intake below roughly 800 kcal/day reliably elevates rT3. Structured diet breaks, or "re-feeds," every 2 to 4 weeks during weight-loss programs may blunt this effect by temporarily restoring D1 activity. A 2019 paper in Obesity examined metabolic adaptation during caloric restriction and found that rT3 was among the hormones most responsive to re-feeding interventions.

Consider T3-Containing Thyroid Therapy

For patients who have optimized all cofactors and still show a persistently low free T3-to-rT3 ratio with hypothyroid symptoms, a trial of liothyronine added to levothyroxine (typically 5 to 10 mcg of liothyronine twice daily alongside a reduced levothyroxine dose to maintain equivalent T4 exposure) may be appropriate. This approach bypasses the blocked conversion step entirely. Prescribing should follow the Endocrine Society's 2012 guideline cautions, which note that combination therapy carries risk of over-replacement-induced atrial fibrillation and bone loss if not dosed carefully. The Endocrine Society's clinical practice guideline on hypothyroidism management is available through the Journal of Clinical Endocrinology and Metabolism.

How Context Changes the Interpretation

The same rT3 number means different things depending on clinical context. Here are three common scenarios that illustrate why the number alone is insufficient.

Scenario 1: Post-Surgical Patient With rT3 of 28 ng/dL

A 52-year-old recovering from elective hip replacement has rT3 of 28 ng/dL three days post-op, TSH of 1.8 mIU/L, free T4 of 1.1 ng/dL, and free T3 of 2.2 pg/mL. The elevated rT3 is expected non-thyroidal illness syndrome. No thyroid-specific intervention is warranted; re-testing in 6 weeks will likely show normalization.

Scenario 2: Fatigued 38-Year-Old on Levothyroxine With rT3 of 22 ng/dL

TSH is 1.4 mIU/L (within range), free T4 is 1.3 ng/dL (within range), but free T3 is 2.1 pg/mL (low-normal) and rT3 is 22 ng/dL. The free T3-to-rT3 ratio is 2.1 divided by 22, which equals 0.095, well below the 0.18 threshold (equivalent to 1.8 when free T3 is expressed in pg/mL and rT3 in ng/dL). Ferritin comes back at 32 ng/mL, and selenium is 61 mcg/L. This patient has identifiable nutritional deficits as likely contributors; iron and selenium optimization should precede any medication change.

Scenario 3: Patient on Cytomel (Liothyronine) 25 mcg Twice Daily With rT3 of 7 ng/dL

Low rT3 here is a pharmacologic finding. Exogenous T3 suppresses endogenous T4 production, reducing the substrate available for rT3 synthesis. The result is expected and does not indicate pathology. The clinical focus should be on whether free T3 and TSH are within therapeutic targets, not on the rT3 value.

Practical Steps Before Your Appointment

Getting the most useful information from an rT3 test requires proper context. Order rT3 alongside TSH, free T4, free T3, TPO antibodies, ferritin, serum selenium, and a morning cortisol. Blood should be drawn in the morning (7 to 9 a.m.) in a fasted state to minimize diurnal variation in cortisol, which affects deiodinase activity acutely.

Bring your result printout with the laboratory's reference ranges to your appointment. If rT3 is the only thyroid test ordered, ask your clinician to add free T3 so the ratio can be calculated. A single rT3 number without free T3 cannot be meaningfully interpreted.

The National Institutes of Health MedlinePlus thyroid testing overview provides a useful patient-oriented summary of the full thyroid panel and what each component measures.